Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | REN | P00797 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5353995 | 0.99 | ALDH1A1 (0.48) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5349928 | 0.92 | ALDH1A1 (0.48) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5756654 | 0.90 | ALDH1A1 (0.61) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL5350078 | 0.89 | ALDH1A1 (0.60) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5354964 | 0.86 | ALDH1A1 (0.47) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5361599 | 0.86 | ALDH1A1 (0.48) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5350359 | 0.85 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2KMT2AGAAMEN1 | |
| SCHEMBL5353545 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5348668 | 0.83 | ALDH1A1 (0.48) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL5362293 | 0.83 | ALDH1A1 (0.53) | ALDH1A1CPB2SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0997147-B1 | AMINO ACID DERIVATIVES | ONO PHARMACEUTICAL CO (JP) | 2006-03-15 | — | — | EP | claimed |
| US-20030013725-A1 | Amino acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2003-01-16 | — | — | US | claimed |
| EP-0997147-A1 | AMINO ACID DERIVATIVES | Ono Pharmaceutical Co., Ltd. (JP) | 2000-05-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | CACNA1B, SCN1A, SCN2A | ALDH1A1 3065/4885CPB2 3716/4885SMN1; SMN2 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.